UJS-24236-42658
4 vaccinations
2 coded responses
28 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 974 / OR
- Registered
- 2020-12-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-31
Registered in v-safe
-
2020-12-31
Dose 1 — Moderna
- 2020-12-31
- 2021-01-04
- 2021-01-05
- 2021-01-06
- 2021-01-07
- 2021-01-16
- 2021-01-21
-
2021-01-28
Dose 2 — Moderna
-
2021-01-28
Survey response — 0 day, dose 2MedDRA: Flushing — Feeling: Fair · Site: Pain · Fatigue or tirednessMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-01-29
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-12
- 2021-02-18
- 2021-02-27
- 2021-03-04
- 2021-03-11
-
2021-04-13
Pregnancy registry surveyNot pregnant at or since vaccination ·
- 2021-04-29
- 2021-07-29
-
2022-08-18
Dose 3 — Pfizer-BioNTech
-
2022-11-03
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-11-19
Survey response — 14 day, dose 4MedDRA: Pulmonary hypertension — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitMedDRA releases: 2024-11 · check-in answers available
-
2022-11-19
Report sent to call center — 14 day, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2022-11-21
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-11-24
- 2022-12-08
- 2022-12-15
- 2023-02-02
- 2023-05-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-31 | Moderna | |
| 2 | 2021-01-28 | Moderna | |
| 3 | 2022-08-18 | Pfizer-BioNTech | No |
| 4 | 2022-11-03 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-11-19 | Successful 2022-11-21 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 2
Systemic reaction (other): flush
Release 12
Symptoms: Pulmonary Hypertension
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pulmonary hypertension | · | · | ✓ |
| SRO | Flushing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release